NCT01035320View on ClinicalTrials.gov

Platelet Function in Diabetic Patients With and Without Renal Impairment, and the Effects of Lipid Lowering Treatment

PHASE4CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
Diabetes MellitusImpaired Renal Function
Interventions
DRUG

Ezetimibe

After a placebo only run-in period patients (two groups) are treated with simvastatin + ezetimibe and simvastatin + placebo in a cross-over trial. Ezetimibe effects on top of simvastatin will be evaluated as the primary aim; simvastatin effects compared to run-in on placebo will be evaluated as a secondary aim.

Trial Locations (1)

171 76

Department of Medicine, Clinical Pharmacology Unit, Karolinska University Hospital (Solna), Stockholm

All Listed Sponsors
collaborator

Danderyd Hospital

OTHER

lead

Karolinska Institutet

OTHER

NCT01035320 - Platelet Function in Diabetic Patients With and Without Renal Impairment, and the Effects of Lipid Lowering Treatment | Biotech Hunter | Biotech Hunter